Tuesday, June 18, 2024


“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce


First Postpartum Depression Drug Fast Tracked and Licensed by FDA

postpartum depression

On Aug. 4, 2023, the U.S. Food and Drug Administration (FDA) fast tracked licensure of the oral prescription medication Zurzuvae (zuranolone), manufactured by Sage Therapeutics, Inc. as a treatment for postpartum depression. Postpartum affects roughly one in seven women and typically begins after childbirth but, for some women, it can begin during later stages of […]

COVID-19 Hospitalized Patients and Underlying Chronic Disease

patient in ICU

Story Highlights Recent research shows that most hospitalized COVID-19 patients had one or more chronic poor health conditions, such as obesity, hypertension and heart and lung disease. Chronic diseases are the leading cause of death and disability in the United States, making the U.S. population susceptible to more severe COVID-19 infections. Good nutrition helps reduce […]

Search in Site

To search in site, type your keyword and hit enter